Manufacturer record
Rica Enterprises: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Rica Enterprises (Himachal Pradesh) were declared Not of Standard Quality between September 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: M24114F, Meropenem for Injection IP 1gm (exp Sep 2026). RDTL, Hubli, Karnataka (state lab) found it not of standard quality: Tests for Clarity of solution and Particulate Matter. Listed in the August 2026 alert.
Records by type
2 records linked to Rica Enterprises in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Meropenem for Injection IP 1gm | Batch M24114FMfg Oct 2024 · Exp Sep 2026 | Tests for Clarity of solution and Particulate MatterParticulate matter | RDTL, Hubli, KarnatakaState lab | Aug 2026 |
| Moxilase-CV Amoxycillin & Potassium Clavulanate Injection IP | Batch B24154Mfg Nov 2024 · Exp Apr 2026 | Test of Clarity of solution, Particulate matter, and Assay of Potassium Clavulanate equivalent to Clavulanic AcidAssay | CDL, KolkataCDSCO lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.